On 12 March 2020, the Paul-Ehrlich-Institut informed the public on supply problems with pneumococcal vaccines on its website. English labelled Prevenar 13 will be commercially available, as from 28 April 2020. These doses will supplement the regular deliveries. The importation of the product was supported by a permission pursuant to Section 79 (5) German Drug […]